GlassScriptPhysician profile
Douglas B Moss
NPI 1609801687
$1,798.43
in general payments reported to CMS, 2019-2025
20 companies · $58.89 in 2025
The $58.89 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $210 · 2021: $384 · 2022: $177 · 2023: $402 · 2024: $240 · 2025: $58.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $562.27 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $388.23 | 2019-2024 | Regranex, Collagenase Santyl, Grafix Pl |
| Melinta Therapeutics, LLC | $118.48 | 2021-2022 | |
| Kerecis Limited | $117.82 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Mimedx Group, INC. | $72.56 | 2024-2025 | |
| Horizon Therapeutics Plc | $70.58 | 2021-2023 | Krystexxa |
| Next Science LLC | $66.36 | 2023 | Blastx, Xperience, Surgx |
| Hydrofera LLC | $62.05 | 2024 | Hydrofera Blue |
| Convatec INC. | $59.63 | 2023-2024 | |
| Musculoskeletal Transplant Foundation INC. | $48.04 | 2022 | |
| Sunovion Pharmaceuticals INC. | $42.73 | 2019 | |
| Solventum Corporation | $33.41 | 2024-2025 | Kerramax Care, Activ.A.C. |
| Janssen Pharmaceuticals, INC | $30.74 | 2019 | |
| Kci USA, INC. | $29.01 | 2023 | Activ.A.C. |
| Linvatec Corporation | $19.62 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $19.45 | 2019 | |
| Molnlycke Health Care US, LLC | $19.00 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.66 | 2024 | Nuzyra |
| Pfizer INC. | $13.33 | 2021 | |
| Hartmann USA, INC. | $10.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.